Aristo Bio-Tech & Lifescience Share Price Today | Stock Price & Aristo Bio-Tech & Lifescience Share Screener
Track the current Aristo Bio-Tech & Lifescience share price and stock price live with TickJournal's free stock screener. Check Aristo Bio-Tech & Lifescience yearly highs lows for the annual price range and momentum. Use the Aristo Bio-Tech & Lifescience stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Aristo Bio-Tech & Lifescience opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Aristo Bio-Tech & Lifescience Share Price Chart
Track the current stock price of Aristo Bio-Tech & Lifescience with an interactive chart. Analyse ARISTO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aristo Bio-Tech & Lifescience stock quote in one place.
Aristo Bio-Tech & Lifescience Company Profile - Fundamental Screener
Screen Aristo Bio-Tech & Lifescience company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ARISTO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Pesticides & Agrochemicals industry, and it trades under ISIN INE082101010.
Company Details
Classification
Identifiers and Leadership
Aristo Bio-Tech & Lifescience Balance Sheet Screener
Screen ARISTO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹155, up from ₹141 in 2025.
Latest statistics put total assets at ₹155 and shareholder funds at ₹44, with a leverage ratio of 0.70.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 155 | 141 | 127 | 100 | 77 | 81 | 88 | 91 | 89 | 87 |
| Current Assets | 130 | 116 | 105 | 83 | 63 | 69 | 77 | 81 | 81 | 84 |
| Fixed Assets | 24 | 24 | 22 | 16 | 14 | 12 | 8 | 8 | 3 | 2 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 8 | 8 | 10 | 10 | 11 | 12 | 11 | 7 | 11 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 44 | 37 | 34 | 30 | 15 | 13 | 12 | 11 | 9 | 5 |
| Share Capital | 7 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 1 | 1 |
| Reserves & Surplus | 37 | 31 | 27 | 23 | 10 | 8 | 7 | 6 | 8 | 4 |
Aristo Bio-Tech & Lifescience Income Statement Screener - Profit & Revenue Analysis
Screen Aristo Bio-Tech & Lifescience income statement and profit fundamentals. Analyze ARISTO quarterly results. Aristo Bio-Tech & Lifescience reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹364 and net profit of ₹7.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 0 | 364 | 319 | 245 | 218 | 166 | 167 | 201 | 202 | 272 | 161 | 58 |
| Expenses | 0 | 348 | 309 | 237 | 209 | 161 | 163 | 197 | 195 | 264 | 158 | 56 |
Operating Costs and Margins | ||||||||||||
| EBITDA | 0 | 17 | 10 | 9 | 9 | 6 | 4 | 5 | 7 | 8 | 4 | 1 |
| Operating Profit % | 0.00% | 4.00% | 3.00% | 3.00% | 4.00% | 3.00% | 3.00% | 2.00% | 3.00% | 3.00% | 2.00% | 2.00% |
| Depreciation | 0 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Interest | 0 | 4 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 1 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | 0 | 10 | 6 | 5 | 5 | 2 | 2 | 1 | 4 | 6 | 3 | 1 |
| Tax | 0 | 3 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 |
| Net Profit | 0 | 7 | 4 | 4 | 4 | 2 | 1 | 1 | 3 | 4 | 2 | 0 |
| EPS | 0.00 | 10.55 | 5.97 | 5.72 | 6.72 | 2.93 | 2.15 | 2.02 | 5.66 | 37.41 | 18.53 | 3.98 |
Aristo Bio-Tech & Lifescience Cash Flow Screener - Liquidity Fundamentals
Screen ARISTO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹9, and net cash flow was an inflow of ₹2.
Over the same period, investing activities used ₹3 and financing activities used ₹4.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 9 | 10 | 8 | -3 | 7 | 2 | 1 | 8 | 1 | -4 |
| Investing Activities | -3 | -5 | -7 | -4 | -3 | -2 | -2 | -2 | -5 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | -4 | -4 | -2 | 8 | -3 | -1 | 1 | -6 | 4 | 4 |
| Net Cash Flow | 2 | 1 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Aristo Bio-Tech & Lifescience Shareholding Pattern Screener
See Aristo Bio-Tech & Lifescience shareholding pattern with promoter, FII, and DII holdings. Check Aristo Bio-Tech & Lifescience promoter holding and ownership changes for ARISTO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 73.42%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.28%, spread across 453 shareholders.
The shareholder count was 453 in 2026-Mar, compared with 512 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Apr |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 73.42% | 73.42% | 73.42% | 73.37% | 73.37% | 73.37% | 73.37% | 100.00% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.28% | 23.10% | 24.14% | 24.18% | 23.69% | 22.14% | 22.84% | 0.00% |
| Other Holding | 2.30% | 3.48% | 2.44% | 2.44% | 2.94% | 4.49% | 3.78% | 0.00% |
| Shareholder Count | 453 | 512 | 468 | 742 | 625 | 660 | 652 | 7 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aristo Bio-Tech & Lifescience. Aristo Bio-Tech & Lifescience dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.60 per unit for 2026-March, a yield of 0.63%, compared with ₹0.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.60, ₹0.50 and ₹0.40 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.60 | 0.63% |
| 2025-March | ₹0.50 | 0.67% |
| 2024-March | ₹0.40 | 0.34% |
| 2023-March | ₹0.25 | 0.40% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Aristo Bio-Tech & Lifescience Stock Index Membership - Nifty & Sensex
See which indices include Aristo Bio-Tech & Lifescience stock. Check ARISTO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Aristo Bio-Tech & Lifescience Market Events Screener - Corporate Actions
Get Aristo Bio-Tech & Lifescience corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aristo Bio-Tech & Lifescience stock events that may affect ARISTO share price, along with derivatives, futures and options activity and sector gainers.
9 corporate actions are listed, the most recent entry being Dividend dated September 23, 2026, with a record date of September 23, 2026.
It is followed by Quarterly Result Announcement dated May 30, 2026 and Quarterly Result Announcement dated November 14, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Dividend | ₹ 0.60 /share | 2.00% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -5.26% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 4.41% |
| 2025-09-01 | 2025-09-01 | Dividend | ₹ 0.50 /share | -2.74% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -13.36% |
| 2024-09-20 | 2024-09-20 | Annual General Meeting | NA | 4.90% |
| 2024-09-13 | 2024-09-13 | Dividend | ₹ 0.40 /share | 34.07% |
| 2023-09-15 | 2023-09-15 | Dividend | ₹ 0.25 /share | 37.55% |
Aristo Bio-Tech & Lifescience Competitors Screener - Peer Stocks Comparison
Screen ARISTO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 45,784 | 19.54 | 52,502 | 11.41% | 2,220 | 35.35 |
| PI Industries | 34,947 | 29.95 | 7,024 | -15.59% | 1,321 | 37.99 |
| Sumitomo Chemical | 21,760 | 37.15 | 3,385 | 3.56% | 543 | 24.89 |
| Bayer Crop Science | 16,349 | 22.12 | 5,770 | 3.16% | 689 | 13.50 |
| Sharda Cropchem | 6,577 | 10.39 | 5,410 | 23.53% | 681 | 33.33 |
| Dhanuka Agritech | 4,150 | 13.92 | 2,071 | 15.49% | 297 | 33.36 |
| Rallis | 3,889 | 31.33 | 2,631 | 6.54% | 164 | 32.48 |
| NACL Industries | 3,168 | 249.62 | 1,587 | 27.74% | 5 | 19.81 |
| Bhagiradha Chemicals & Industries | 3,089 | 112.38 | 538 | 19.68% | 18 | 29.92 |
| GSP Crop Science | 2,201 | 22.16 | 1,531 | 17.66% | 95 | 30.71 |
Aristo Bio-Tech & Lifescience Company Announcements - News & Reports Screener
Screen ARISTO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.48. Market capitalisation stands at ₹64.67 Cr and the dividend yield is 0.63%. The company operates in the Chemicals sector, in the Pesticides & Agrochemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 12 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.